-
Gap19: Selective Cx43 Hemichannel Blocker
2026-08-27
Gap19 is a selective connexin 43 hemichannel blocker designed to separate Cx43 hemichannel signaling from gap junction communication. Product-reported findings support investigation of astrocyte ATP release, cerebral ischemia, and ischemia/reperfusion injury, while a peer-reviewed macrophage study links Gap19-sensitive Cx43 signaling to NF-κB activation.
-
Allosteric PDK4 Inhibitors for Metabolic Disease
2026-08-26
The 2019 Journal of Medicinal Chemistry study identified anthraquinone-derived allosteric inhibitors of pyruvate dehydrogenase kinase 4, highlighting compound 8c as a potent biochemical inhibitor with activity in metabolic, allergic, and cancer-related models. Its combination of hit optimization, pharmacology, metabolic stability, and docking provides a useful preclinical framework for developing PDK4-directed therapies, while leaving important questions about selectivity, target engagement, and clinical translation unresolved.
-
8-Chloroadenosine for RNA Workflows
2026-08-26
8-Chloroadenosine is a high-purity nucleoside analog for testing how transcriptional suppression reshapes RNA abundance, stability, and downstream cancer-cell phenotypes. This workflow-focused guide connects product handling with the RP3-340N1.2–IL-6 mechanism reported in NSCLC and emphasizes controls that separate RNA decay from nonspecific toxicity.
-
Phosphatase Inhibitor Cocktail 2: Workflow Guide
2026-08-25
Preserve phosphorylation-dependent biology from tissue harvest through Western blotting, co-immunoprecipitation, kinase assays, and imaging workflows. This practical guide shows how a 100X aqueous cocktail can improve sample consistency while avoiding common matrix, storage, and assay-compatibility problems.
-
Bestatin (Ubenimex): From Enzyme Tool to Translation
2026-08-25
Bestatin (Ubenimex) is more than a conventional aminopeptidase inhibitor. Its selective biochemical profile, context-dependent effects in fibrin-based angiogenesis models, and relevance to multidrug resistance research make it a valuable tool for connecting enzyme inhibition with translational phenotypes.
-
Ionomycin Free Acid in FAK–TNBC Research
2026-08-24
A translational guide to using Ionomycin free acid as a controlled calcium perturbation tool for investigating FAK stability, Calpain 2-mediated proteolysis, and the FAISL axis in triple-negative breast cancer research.
-
RBMS1 Loss Enables PD-L1 Blockade in TNBC
2026-08-24
This Cell Death & Differentiation study identifies the RNA-binding protein RBMS1 as an immune-suppressive regulator in triple-negative breast cancer. RBMS1 depletion destabilizes B4GALT1 mRNA, reduces PD-L1 glycosylation and stability, and improves the activity of checkpoint blockade and CAR-T-cell approaches in experimental models.
-
TRPV1+ Nerve Stimulation Suppresses Inflammation
2026-08-23
Song et al. show that stimulating TRPV1-positive peripheral sensory nerves at the nape suppresses systemic inflammation through coordinated somatic, brainstem, autonomic, and splenic pathways. The study identifies a somato-autonomic reflex involving catecholamine release, vagal-adrenal signaling, and inflammation-related splenic gene regulation, providing a mechanistic framework for neuroimmune intervention studies.
-
L-Ornithine in Urea Cycle Research
2026-08-22
Build reproducible urea cycle, OTC, and astrocyte metabolism assays with high-purity L-Ornithine and an aqueous-first workflow. Translate liver–brain axis findings into practical dose-response, enzyme, metabolomics, and troubleshooting strategies.
-
Isradipine (Dynacirc): Neurovascular Workflows
2026-08-22
Isradipine (Dynacirc) provides a practical way to probe L-type calcium entry across neuronal and vascular models, linking neuroprotective studies with vascular smooth muscle relaxation. This guide combines compound handling, electrophysiology, assay design, and subtype-aware troubleshooting for more reproducible calcium-channel experiments.
-
Zolmitriptan Workflows for Migraine Research
2026-08-20
Build reproducible Zolmitriptan assays around receptor subtype selectivity, solvent control, and time-resolved neurovascular readouts. This practical guide also shows how lysosomal research workflows can inspire assay design without overstating evidence for antiviral or TFEB activity.
-
Redox-Responsive Peptide Coacervates for mRNA Delivery
2026-08-20
Ren and colleagues developed HBpep-SS4, a chemically defined peptide coacervate that combines mRNA encapsulation with glutathione-responsive intracellular release. The system supported diverse RNA cargos and high genome-editing activity, while offering a mechanistically distinct alternative to conventional lipid-based delivery platforms.
-
Olsalazine Sodium: Research Workflows & Uses
2026-08-19
Olsalazine Sodium supports two distinct research tracks: inflammation and colorectal cancer experiments, plus xenobiotic-clearance studies in Aedes aegypti. Its water-compatible formulation, subnanomolar macrophage chemotaxis activity, and reported tumor-model effects make it useful for mechanism-focused assays when dosing, storage, and cross-model interpretation are carefully controlled.
-
Cefodizime: From PBP Mechanism to Translation
2026-08-19
A translational perspective on Cefodizime that connects PBP-directed cell-wall disruption, immune-context experiments, resistance modeling, pharmacokinetic interpretation, and strategically designed antimicrobial research workflows.
-
Biomimetic Chromatography for Lung Permeability
2026-08-18
Dillon and colleagues evaluated mass spectrometry-compatible immobilised artificial membrane liquid chromatography and open-tubular capillary electrochromatography as biomimetic models of pulmonary drug permeability. Their results show that IAM-LC can reproduce important permeability relationships, while OT-CEC adds complementary information about phospholipid-dependent drug–membrane interactions.